NCT01911611View on ClinicalTrials.gov

A Study of RO6870868 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

RO6870868

Single ascending doses

DRUG

placebo

Single ascending doses

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01911611 - A Study of RO6870868 in Healthy Volunteers | Biotech Hunter | Biotech Hunter